Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma

Haematologica

Volumn 90, Issue 7, 2005, Pages 906-913

  González, David ^a   González, Marcos ^a   Balanzategui, Ana ^a   Sarasquete, Maria E ^a   López Pérez, Ricardo ^a   Chillón, M Carmen ^a   García Sanz, Ramón ^a   San Miguel, Jesús F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Gene usage; IgH rearrangements; Incomplete rearrangements; Multiple myeloma; Somatic hypermutation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ALLELE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IMMUNOGLOBULIN GENE; MOLECULAR CLONING; MOLECULAR GENETICS; MULTIGENE FAMILY; MULTIPLE MYELOMA; MYELOMA CELL; POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION;

ANTIBODY DIVERSITY; B-LYMPHOCYTES; FAMILY HEALTH; GENE REARRANGEMENT; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN JOINING REGION; IMMUNOGLOBULIN VARIABLE REGION; MULTIPLE MYELOMA; NUCLEIC ACID HETERODUPLEXES; POLYMERASE CHAIN REACTION;

EID: 22544461076     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Alt FW, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M et al. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J 1984;3:1209-19.
2. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000;343:37-49.
3. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995;16:237-42.
4. Corbett SJ, Tomlinson IM, Sonnhammer EL, Buck D, Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 1997;270:587-97.
5. Matsuda F, Ishii K, Bourvagnet P, Kuma K, Hayashida H, Miyata T, et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998;188:2151-62.
6. Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J. VDJ recombination. Immunol Today 1992;13:306-14.
7. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol 1994;56:27-150.
8. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 2002;71:101-32.
9. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, et al. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 1995;83:387-95.
10. Kirch SA, Rathbun GA, Oettinger MA. Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly. EMBO J 1998;17:4881-6.
11. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002;20:165-96.
12. Kelsoe G. V(D)J hypermutation and receptor revision: coloring outside the lines. Curr Opin Immunol 1999;11:70-5.
13. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998;162:261-80.
14. Stavnezer J. Antibody class switching. Adv Immunol 1996;61:79-146.
15. Kosmas C, Stamatopoulos K, Stavroyianni N, Zoi K, Belessi C, Viniou N, et al. Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire. Leukemia 2000;14:1718-26.
16. Sakai A, Marti GE, Caporaso N, Pittaluga S, Touchman JW, Fend F, et al. Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood 2000;95:1413-9.
17. Rao SP, Riggs JM, Friedman DF, Scully MS, LeBien TW, Silberstein LE. Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection. J Immunol 1999;163:2732-40.
18. Szczepanski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJ, van Wering ER, et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage. Blood 1999;93:4079-85.
19. + B cells. J Clin Invest 1997;99:2488-501.
20. Chapman CJ, Mockridge CI, Hamblin TJ, Stevenson FK. Tracking of the V4-34 (VH4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation. Clin Exp Immunol 1996;105:360-8.
21. Kiyoi H, Naito K, Ohno R, Naoe T. Comparable gene structure of the immunoglobulin heavy chain variable region between multiple myeloma and normal bone marrow lymphocytes. Leukemia 1996;10:1804-12.
22. Hsu FJ, Levy R. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995;86:3072-82.
23. Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA. Immunoglobulin V gene expression in CD5 B-cell malignancies. Ann NY Acad Sci 1992;651:373-83.
24. Damle RN, Wasil T, Fais F, Ghiotto F, Valette A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-7.
25. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
26. Tobin G, Thunberg U, Johnson A, Eriksson I, Soderberg O, Karlsson K, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003;101:4952-7.
27. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841-94.
28. Rettig MB, Vescio RA, Cao J, Wu CH, Lee JC, Han E, et al. VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood 1996;87:2846-52.
29. Gonzalez D, Balanzategui A, Garcia-Sanz R, Gutierrez N, Seabra C, van Dongen JJ, et al. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications. Leukemia 2003;17:1398-403.
30. Gonzalez M, Gonzalez D, Lopez-Perez R, Garcia-Sanz R, Chillon MC, Balanzategui A, et al. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies. Haematologica 1999;84:779-84.
31. van Dongen JJ, Langerak AW, Bruggemann M, Evans FA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
32. Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero IL, van Dongen JM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997;11:2192-9.
33. Lefranc MP. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2001;29:207-9.
34. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetta A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-25.
35. Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994;15:367-73.
36. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991;173:395-407.
37. Huang C, Stewart AK, Schwartz RS, Stollar BD. Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest 1992;89:1331-43.
38. Wasserman R, Ito Y, Galili N, Yamada M, Reichard BA, Shane S, et al. The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage. J Immunol 1992;149:511-6.
39. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190-202.
40. Kraj P, Rao SP, Glas AM, Hardy RR, Milner EC, Silberstein LE. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J Immunol 1997;158:5824-32.
41. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992;149:2337-44.
42. Kraj P, Friedman DF, Stevenson F, Silberstein LE. Evidence for the over-expression of the VH4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. J Immunol 1995;154:6406-20.
43. Deane M, Baker BW, Norton JD. Immunoglobulin VH4 gene usage in B lymphoid leukaemias. Br J Haematol 1993;84:242-9.
44. Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001;108:1061-70.
45. Ramsden DA, Wu GE. Mouse κ light-chain recombination signal sequences mediate recombination more frequently than do those of λ light chain. Proc Natl Acad Sci USA 1991;88:10721-5.
46. Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P, et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 1995;181:1507-17.
47. Ghiotto F, Fais F, Valetta A, Albesiano E, Hashimoto S, Dono M, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004;113:1008-16.